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The selection of an implantable venous pon over
peripheral venous access must necessarily be subjective
and depends on the condition of the patient's veins, the
skill, patience and experience of the therapist insening
peripheral catheters, and the patient's life expectancy
and the strength of the indication. Many patients with
poor veins prefer the certainty of venous access for
therapy and blood sampling, to the anxiety accompany-
ing multiple attempts to access peripheral veins. Despite
the advantages of implanted devices, the cost is signifi-
cant and the complications, though uncommon, may be
serious. Every technique should be used to enhance the
success of peripheral venous cannulation (warming the
limb or hand, obtaining adequate proximal venous com-
pression, etc.), before considering an implanted device.
We wish to acknowledge the assistance of the following
nurses, physicians and surgeons who were substantially
involved in the care of these patients and their Port-a-caths:
Blais, Diane, R.N., Corringham, Robert, M.D., Germond,
Colin, M.D., Goss, Glenwood, M.D., Helie, Gilles, M.D.,
Kane, Gabrielle, M.D., Perreault, Claire, M.D., Trottier,
Theresa, R.N., Vincent, Mark, M.D. In addition we wish
to express special thanks to Sue Corringham, Reg. N. for
assistance with data management and computerisation.
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The 'econoll1.ics' of ll1.edical technology
G. G. JARos, D. A. BOONZAIER
Abstract The word 'economics' is used in this paper in its
widest sense, referring to issues that 'influence the
management, regulation and government of an
enterprise'. In addition to the obvious monetary
issues in health-care technology, social, ethical,
legal and cultural issues are also discussed. The
eventual, generally high cost of health care is defi-
nitely influenced to a greater or lesser extent by
these factors. It is suggested that proper evalua-
tion during the planning stage could lead to the
development and introduction of technologies into
health care in a more cost-effective way.
S Air Med J 1993; 83: 416-419.
O
ne of the greatest technological achievements of
mankind was the marriage of the horse and cart
for transport purposes. This marvellous combi-
nation of energy source and low-friction vehicle made it
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possible for man to open up the interior of continents
for travel and commerce. The example of the wheeled
horse-cart with a good driver highlights the importance
of choosing the righr combination of technology and
techniques to allow available resources to be usefully
directed.
In the last 100 years or so there has been an abiding
hope that the increasing application of technology to
problem areas could likewise conquer disease. Is this
hope being realised or is there something amiss? There
are dark rumblings about the side-effects and dangers of
rechnology; an increasingly anti-science culture pro-
poses a 'back to the earth' philosophy. The concept of
'health-care technology' is provoking more and more
ambivalence. If we do not address these concerns as a
matter of urgency, there is a real danger that the whole
health-care cart will come crashing down, patienrs and
all.
The word 'economics' is used in this paper in its
widest sense, viz. 'the management, regulation and
governmenr of a household'. As such it does not refer
simply to monetary considerations, but in the conrext of
health care, to the much broader societal implications.
Health is probably the most valuable of all human
attributes, yet we often take it for granted and place it at
risk. Paradoxically, once we have lost it we are prepared
to do anything ar any price to regain it. Cosrs seem to
---....,.....-------~
take a back seat when we are dealing with curative
health care.
Although the bottom line in health care remains
fmancial considerations, the individual items must be
carefully considered. Economists and medical practi-
tioners alone cannot provide solutions to the economic
problems in health care. These problems are multi-
faceted and need to be examined by properly equipped
teams, which need the input of a range of people, viz.
managerial, ethical, legal and sociological experts, apan
from those of the above professions.
The present
Health-care technology is developing at an alarming
rate. This phenomenon has been a cause for serious
concern to health-care administrators for a number of
years. I It is widely accepted that technology can offer
many benefits and has therefore greatly enhanced our
ability to prevent, diagnose and treat disease. However,
unlike other technologies, health-care technology has
brought with it a disproportionate escalation of costs -
both monetary and non-monetary. The monetary cost
includes not only the cost of equipment but associated
overheads of a magnitude which generally overshadows
the former. These include highly trained staff and
expensive maintenance and repair.
When one talks about the 'economics of medical
technology one has to consider the non-monetary prob-
lems which manifest themselves as questionable effec-
tiveness and appropriateness, unequal distribution of
services caused by over-specialisation and centralisation,
dehumanising tendencies, and social, legal and ethical
problems' .'
The unequal distribution ofhealth care
During the 18th and 19th centuries medical science
progressed relatively slowly, but the 1900s have seen
rapid acceleration, particularly during the last 50 years.
In the early days disease was diagnosed by the doctor
after looking at the patient and listening to his com-
plaints. No physical contact occurred and some doctors
even performed diagnosis by mail! Later it became
acceptable practice to use hands for palpation and only
in the last century did diagnostic instruments, such as
the stethoscope, start to be used. Only in the last 50
years have medical devices become inordinately com-
plex and at the same time expensive. 3
This complexity of technology made doctors tend to
specialise and the expense saw them and their equip-
ment become concentrated in hospitals. Technology-
rich, expensively staffed hospitals developed in big
cities, leaving the rural areas without adequate health-
care services. This phenomenon occurred not only in
South Africa but also in such higWy developed coun-
tries as the USA. The effects of maldistribution of
medical resources are probably more acute in develop-
ing nations, but in countries like South Africa, in which
the First and Third Worlds exist side by side, the situa-
tion is exacerbated. With the rapid migration of people
to the Outskirts of cities the situation is brought 'closer
to home'.
Peri-urban health needs comprise more than just
curative medical treatment, and extend to adequate
housing, diet, sanitation, stress-free environment, secu-
rity and good working conditions. Only when these fac-
tors are adequately addressed can one start to talk
meaningfully about improved health care. Until then
one can only hope to alleviate the situation somewhat.
But as things stand today even alleviation is very diffi-
cult. There is a shortage of doctors in both rural and
peri-urban areas and the educational/culturallcon-
venience-Ioaded environment of the cities does little to
encourage doctors to work in rural areas. We believe
that only by judicious use of technology can we hope
to solve this situation. Simple, easy-to operate, user-
friendly technologies could be provided for the commu-
nity nurse - the most important person in most pri-
mary care settings - to help her overcome some of the
difficulties she experiences in providing basic health
care, and to improve her effectiveness.
Another aspect of unequal distribution of health care
is highlighted by the imbalance between diagnostic,
curative and life-prolonging services on the one hand
and prevention, promotion and rehabilitation services
on the other. About 90% of total health-care funding is
spent on the first group; what is left over accrues almost
by default to the second. Classic medical expertise is
concentrated and training occurs in high-technology
academic hospital settings with the result that medical
doctors receive only rudimentary training in other con-
texts. We can thus safely say that disease is receiving
more attention than healrh and ask whether we are really
justified in calling the process 'health care' under these
circumstances.
There are two possible ways to solve this problem.
The first, which is unlikely to succeed, is for the medical
profession itself to redirect its priorities to primary care,
prevention and rehabilitation, and away from the pre-
sent emphasis on clinical medicine. A second solution
could come from employing appropriate technologies
together with those people who are suitably trained to
utilise these technologies. It must be remembered that
many of the problems in South Africa are unique local
problems that cannot be solved by imported technolo-
gies, most of which are designed for use in a different
context. Appropriate solutions must come from those
who are sufficiently interested and have acquired insight
into the problems through first-hand experience.
Effects of the newer technologies
The centralisation of health care and associated techno-
logy in tertiary care institutions has certainly contributed
considerably to the advances in diagnosis and therapy in
these institutions. However, more and more is being
written about the pressures and effects of technology,
which could adversely influence the entire health-care
process!
On the patient, family andfriends
Any new devices and associated procedures have an
impact on the patient and the whole family. Physical
improvement in the patient can 'be accompanied by
psychological decline with family consequences. For
example, chronic home dialysis could disrupt and cause
considerable financial difficulties while restricting the
patient to the vicinity of his home town. The provision
of an artificial hean costing over R300 000 might pro-
vide a questionable increase in quality of life and place
tremendous strain and apprehension on the family.
Although, on the face of it, computer-aided record
collection might be cheaper, it might depersonalise the
doctor-patient relationship and raise problems with
regard to confidentiality of clinical information.
On society as a whole
The prolongation of life of those with genetic diseases
by technological means will certainly change the genetic
pool of society and can lead to demographic redistribu-
tion of the health status of an entire population. This, in
turn, can change social institutions or put inordinate
strain on them.
On legal and political systems
The increasing deployment of new technologies raises
ethical and legal questions. Makers of devices have to
face liability actions; those using them are increasingly
subjected to malpractice suits. These additional costS, in
turn, influence legislative pressures on the political
machinery required to effect changes. Political responses
include efforts to redirect available health-eare resources
to the various sectors of the population as technology
modifies the demographics of disease.
On the economic system
Technology can have both positive and negative effects
on the economic system. Increased productivity can
result when disease is prevented or when a' person is
properly rehabilitated. It can also put extra burdens on
society if life-saving technologies increase the ratio and
number of people on welfare due to disability and/or
age.
On the medical care system
Technology can demand new specialists and cause
others to become redundant: for instance the availability
of digital imaging systems, especially magnetic reso-
nance imaging and computed tomography, has to a
large extent made radio-isotope scanning obsolete, as
well as the expert staff needed to conduct it. The
changes can affect the educational requirements of all
those involved in the delivery of health care. For exam-
ple, \vith the new information-processing technologies,
de-emphasis of encyclopaedic knowledge on the pan of
the medical practitioner might free him to adopt a more
analytical approach.
These are but a few examples of ways in which
health care technology can adversely or favourably affect
our lives and the lives of those around us.
The pressures of technology on the
medical profession
Financial pressure
There are strong fiscal incentives for including high-
technology methodologies in diagnosis and treatment.
Doctors can charge a higher fee for a shorter examina-
tion using sophisticated equipment than for a thorough
but non-technological examination. To obtain sophisti-
cated equipment is a good investment, with favourable
tax incentives and good return on capital, while there
are no rewards for not using technology. Medical insur-
ance usually pays for claims involving high-technology
investigations without questioning the need for it.
Doctors are thus encouraged and rewarded for replacing
quality clinical time with high technology. In the USA,
doctors often order many unnecessary special investiga-
tions to help thwart malpractice claims.
Peer pressure
Medical doctors are trained in tertiary health-care
centres, where they get used to and became dependent
on the newest technologies. Equipment which produces
numbers or graphs on oscilloscopes and charts gives a
semblance of scientific rigour and accuracy and leads to
the so-called 'gadget syndrome', which reflects trendi-
ness, devotion to a certain technology, and even profes-
sional competition and jealousy. Unfortunately, in
medical schools there is insufficient training in the work-
ing principles, advantages, limitations and dangers of
using these technologies, including economic compari-
son between alternatives. A trainee doctor might do a
test for fear of being reprimanded for not doing so. Few
doctors are reprimanded for doing too many tests.
Insufficient knowledge of the costlbenefit ratio com-
pounds the situation and precludes discussion and
debate.
Patient demands and public awareness
When sick, we as patients quite reasonably want the best
treatment possible. We associate the best with the most
recently instituted, under the dubious assumption that
technology undergoes continuous improvement.
Unfonunately, the popular press is to a great extent to
blame for trumpeting spectacular advances in techno-
logy without giving sufficient coverage to the state of
development, side-effects and limitations, including
costs. It is the duty of developers and users to point
these out to the media. Unfonunately, the newswort:hT-
ness of the negative side-effects can never compete with
the sensationalist possibilities of a new cancer cure story.
Moral and ethical pressures
Innovative technologies also introduce new moral and
ethical issues and dilemmas. Technology is playing an
important role in the definition and determination of
death. The routine use of life-support technologies
poses questions concerning when to terminate treatment
with the 'heroics' of life-at-all-costs becoming the norm
in the USA. Unquestioning application of these tech-
nologies in a milieu of constrained financial resources
raises the question about who should be treated and on
what basis this should be decided. Other vexing legal
and moral issues which remain far from resolved con-
cern clinical experimentation, organ donation/storage/
transport/transplantation and various artificial fertilisa-
tion/implantation techniques.
The law has yet to come to grips with the clinical and
moral dilemmas raised by these procedures, and pro-
vides little guidance or protection to progressive practi-
tioners.
Time pressure
It seems that many of these 'advances' emerge too fast
for comfort. Technologies become obsolete before they
have matured and established themselves and there is
not enough time critically to evaluate and respond to the
consequences of technological interventions. This
'shortage of time' can lead to loss of control over patient
and disease and thus to the dehumanising of patient
care. One might ask: 'Why are we in such a hurry to
introduce the newest technologies?' We have been with-
out them for millions of years. The couple of years
needed to evaluate a technology thoroughly might be a
worthwhile investment to ensure that the right questions
are asked with regard to its overall efficacy.
Legal liability
The complex mechanical and electrical nature of most
technologies brings to the fore the safety aspects, which
involve both patients and staff. The possibility of diag-
nostic errors arising despite correctly functioning equip-
ment further complicates the situation. Legal cover
against possible erroneous diagnosis or inappropriate
treatment adds a tremendous financial burden to medi-
cal doctors and equipment manufacturers. Certainly in
the USA insurance premiums are crippling and, to
avoid malpractice suits, 'defensive medicine' demands
excessive diagnostic and therapeutic procedures. A
trend towards this 'unhealthy' state of affairs is clearly
evident in South Africa.
Complexity
Medical knowledge is growing logarithmically, with ever
more sophisticated technologies continuously emerging.
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Meanwhile, the practising medical doctor is hard pur to
stay abreast of the latest advances. Complexity also
manifests itself in the increasing amount of diagnostic
information a doctor must routinely digest in order to
make rational clinical decisions. There is a fear that
medical doctors are now in danger of becoming mana-
gers of information rather than curers and comforters of
the sick.
.The cost ofhealth care
The runaway cost of health-care technology has been
causing concern in many quarters over the last S years.
In the conventional industrial setting new technologies
are either cost-reducing or benefit-increasing or both.
By contrast health-care costs generally increase mono--
tonically with greater effectiveness and/or quality.' The
reasons for this difference in ourcome include the fol-
lowing.
Initial capital invest:ment. This is high in many
instances, bur the spread of cost over many years causes
amortised equipment cost per diagnosis or treatment to
be low.
The equipment component of a 20-bed intensive
care unit (ICD) (including ventilators, monitors, radio-
graphic equipment and even 'high-tech' beds) costs in
the region of RI million. Calculated on a cost per
patient basis, this is only abour 2 - 3% of the total aver-
age cost of daily hospitalisation in an lCU. Similarly,
computerised tomography and auroanalyser equipment
cost RI,S million and RSOO 000 respectively, and indi-
vidual tests appear relatively inexpensive. This creates a
false impression of true costs.
'Invisible' overheads. These comprise the largest
portion of the equipment-related cost. They include
salaries, training programmes, building, maintenance,
consumables, safety monitoring and administration. For
example, the capital equipment costs for clinical labora-
tories in the USA represented only one-fiftieth of the
total national bill for laboratory investigations.
It is especially important to guard against 'creeping
developments', which are sometimes initiated by well-
intentioned charities that donate equipment to hospitals,
which then have to pick up the major part of the bill, i.e.
the running costs. 'Donations' of equipment by com-
panies may not prove as altruistic as they seem when the
training, maintenance and spare parts bills start arriving!
Need for costly follow-up care. The mere avail-
ability of technology generates the temptation to use it
in every case, even in those where the prognosis is poor.
Heroic non-discriminatory use of cardiopulmonary
resuscitation equipment has resulted in ever-larger ICUs
filled with chronically debilitated patients who will never
return to their homes. This problem has reached epi-
demic proportions in the USA.
/
Need for ongoing use. Dialysis, for example, once
instituted, is most commonly maintained indefinitely if
not followed by renal transplantation. For example, in
1984 in the USA renal dialysis cost $12 aaa/person!
year; the resultant cost to the country was about
$1 000 million annually.
IndiscriIninate use. This always results in an
increase in the cost of health care since it results in more
equipment being needed than would otherwise be the
case. The amount of money spent on health care cannot
increase without limits. If the costs are allowed to
expand in one area, e.g. due to unjustified, excessive
usage, they will necessarily have to be reduced in others.
In the USA the introduction of prospective payment
schemes for diagnostic-related groups was designed to
encourage cost-effective deployment of limited
resources. Under this scheme, Medicare insurance pays
hospitals only for the diagnosis of and therapy for a
disease, and not for the particular way this is achieved.
Since its inception a few years ago, this system has
already started 'providing encouraging results. Hospitals
are giving more thorough consideration to the broader
ramifications of new technologies and shying away from
those which increase cost withour clear benefit.
Who should take responsibility?
It is clear that technology in health care is a source of
many problems, ranging from unequal resource distri-
bution, through unwanted effects and unfair pressures
on those involved, to financial considerations. There is a
tendency to blame the medical profession for all the ills
of the health-care system. This is of course to a large
extent unwarranted. A large portion of the responsibility
can be attributed to the technological transformation of
health eare that has not been properly planned and ana-
lysed. We believe that, with proper planning, many of
these problems could have been eliminated or mini-
mised. Even the developers and sellers of these tech-
nologies, with some insightful circumspection, should
have been able to foresee some of the problems and
could have provided leads to health-care planners about
how to deal with them at a relatively early stage.
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